Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
32.15
+0.04 (0.12%)
Sep 2, 2026, 4:00 PM EDT - Market closed
Quince Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Initiates $68 | Buy | Initiates | $68 | +111.51% | Aug 20, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $99 → $98 | Buy | Maintains | $99 → $98 | +204.82% | Aug 19, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $80 → $70 | Buy | Reiterates | $80 → $70 | +117.73% | Aug 18, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $82 | Buy | Reiterates | $82 | +155.05% | Aug 17, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $80 | Buy | Initiates | $80 | +148.83% | Jun 24, 2026 |